참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-Mercaptoethanol | HCID 1567 | — |
| 반응물 | Benzamide | HCID 2331 | — |
| 반응물 | Phenylmethylsulfonyl Fluoride | HCID 4784 | — |
| 반응물 | Thiazolidinedione | HCID 5437 | — |
| 반응물 | Ethylenediaminetetraacetic Acid | HCID 6049 | — |
| 반응물 | Tris(hydroxymethyl)aminomethane | HCID 6503 | — |
| 반응물 | Leupeptin acid | HCID 189069 | — |
| 반응물 | D-1,4-Dithiothreitol | HCID 446094 | — |
| 용매 | Glycerol | HCID 753 | — |
| 생성물 | AD 5075 | HCID 128440 | — |
반응 단계
For each assay, an aliquot of receptor (1:1000-1:3000 dilution) was incubated in TEGM (10 mM Tris, pH 7.2, 1 mM EDTA, 10% glycerol, 7 μl/100 ml β-mercaptoethanol, 10 mM Na molybdate, 1 mM dithiothreitol, 5 μg/ml aprotinin, 2 μg/ml leupeptin, 2 μg/ml benzamide and 0.5 mM PMSF) containing 5-10% COS-1 cell cytoplasmic lysate and 10 nM labeled thiazolidinedione ([3H2 ]AD-5075, 21 Ci/mmole), ± test compound compound, [3H2 ]Example 11, 17 Ci/mmole), ± test compound, respectively. Assays were incubated for ~16 h at 4 ° C. in a final volume of 300 μl. Unbound ligand was removed by addition of 200 μl dextran/gelatin-coated charcoal, on ice, for ~10 minutes. After centrifugation at 3000 rpm for 10 min at 4° C., 200 μl of the supernatant fraction was counted in a liquid scintillation counter. In this assay the KD for AD-5075 and Example 11 is 1 nM, respectively.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06020382 |
|---|
| 출처 데이터셋 | uspto-grants-2000_02 |
|---|
| ORD ID | ord-02cc420f906c4c0687d2f648116f01e1 |
|---|
| 출처 메모 | uspto-grants-2000_02 |
|---|